Therapeutic effects of Spirulina against experimentally-induced non-alcoholic fatty liver in rats may involve miR-21, -34a and -122
Conclusion: Spirulina treatment of HFD-NAFL in rats modulated glucose, insulin sensitivity and showed anti-steatotic properties; effects that could be attributed at least partially to modulating hepatic microRNA expression. In conclusion, Spirulina can be considered as a potential anti-steatotic agent and might provide promising therapeutic approaches in NAFLD.
Source: Meta Gene - Category: Genetics & Stem Cells Source Type: research
More News: Alcoholism | Diets | Fatty Liver Disease (FLD) | Genetics | High Fat | Insulin | Liver | Non-alcoholic Fatty Liver Diseases (NAFLD) | Nutrition | Spirulina | Study | Sugar | Urology & Nephrology